Clinical tools

Your clinical toolkit

Calculators, scales and references nurses reach for every shift — including a deep ICU section for ventilation, ABGs, CRRT, sedation and delirium.

All tools

Every tool in one searchable grid.

Showing 23 of 23 tools
BMI
Enter height and weight to calculate.
BMI is a screening tool, not a diagnostic. Interpret alongside body composition and clinical context.
BSA
Enter height and weight.
BSA-based dosing is approximate — always cross-check against the regimen's preferred formula (Du Bois, Mosteller, Boyd).
Administer
Volume of stock (or number of tablets) to give.
Always double-check high-risk medications with a second nurse and the original order.
Pump rate
Gravity drip
Drop factor is printed on the IV tubing package — confirm before relying on the gtt/min figure.
Estimated CrCl
Enter all fields to estimate.
Use lean or adjusted body weight in obesity. eGFR (CKD-EPI) is preferred for CKD staging.
Ideal Body Weight
Enter height
Adjusted Body Weight
Used when actual > 1.2 × IBW
Heights below 5 ft (152 cm) fall outside Devine's validated range — use clinical judgement.
Target tidal volume
Enter sex and height.
Pair with plateau pressure ≤ 30 cm H₂O. Reduce Vt toward 4 mL/kg if plateau exceeds target.

VC-AC (Volume Control, Assist Control)

Fixed Vt, every breath (mandatory or triggered).

Set
Tidal volume (Vt) · Rate · PEEP · FiO₂ · I:E or flow
Use
ARDS (lung-protective), most general ICU ventilation.
Pros
Guarantees minute ventilation; predictable Vt.
Watch
Pressure varies with compliance — monitor plateau ≤ 30 cm H₂O.

PC-AC (Pressure Control, Assist Control)

Fixed inspiratory pressure; Vt varies with compliance.

Set
Inspiratory pressure · Rate · PEEP · FiO₂ · I:E
Use
ARDS, paediatrics, post-op cardiac.
Pros
Lower peak pressures; better in stiff lungs.
Watch
Vt can fall as compliance worsens — watch tidal volume closely.

SIMV (Synchronized Intermittent Mandatory Ventilation)

Mandatory breaths synchronised with patient effort; spontaneous breaths in between.

Set
Vt or pressure · Rate · PS for spontaneous breaths · PEEP · FiO₂
Use
Weaning bridge (historic), some post-op pathways.
Pros
Allows spontaneous effort between mandatory breaths.
Watch
High WOB if PS is too low; less common as a primary mode today.

PRVC (Pressure Regulated Volume Control)

Targets a set Vt at the lowest pressure possible breath-to-breath.

Set
Vt target · Rate · PEEP · FiO₂ · Pressure limit
Use
Modern default in many ICUs.
Pros
Volume guarantee with pressure control’s comfort.
Watch
Reduces support as compliance improves — may mask deterioration.

CPAP / PS (Pressure Support)

Spontaneous breathing only; PS boosts each patient effort, CPAP holds airway open.

Set
PS level · PEEP / CPAP · FiO₂ · Trigger sensitivity
Use
Weaning, spontaneous breathing trials, OSA.
Pros
Comfortable; preserves diaphragm activity; ideal weaning mode.
Watch
Patient must have reliable respiratory drive; risk of apnoea if oversedated.

PC-BiPAP / BiLevel

Two pressure levels (Phigh / Plow) with spontaneous breathing allowed at both.

Set
Phigh · Plow · Thigh · Tlow · PS for spontaneous breaths · FiO₂
Use
ARDS, COPD, post-op, transition out of deep sedation.
Pros
Combines pressure-controlled ventilation with patient comfort and spontaneous breathing.
Watch
Pressure asynchrony if settings poorly tuned; monitor Vt and patient effort.

APRV (Airway Pressure Release Ventilation)

Prolonged Phigh with brief releases to Plow; spontaneous breathing throughout.

Set
Phigh · Plow · Thigh (long) · Tlow (short, 0.4–0.8 s) · FiO₂
Use
Refractory hypoxaemia, severe ARDS.
Pros
Recruits collapsed alveoli; can improve oxygenation in severe ARDS.
Watch
Auto-PEEP from short release; complex to titrate; sedation balance.

HFOV (High Frequency Oscillatory Ventilation)

Very small Vt at 3–15 Hz; constant mean airway pressure.

Set
Mean airway pressure · Frequency (Hz) · Amplitude (ΔP) · FiO₂
Use
Neonatal/paediatric refractory hypoxaemia (adults rarely).
Pros
Theoretical lung-protective ventilation in severe ARDS.
Watch
No evidence of benefit over conventional in adults (OSCAR/OSCILLATE); now rare.

NIV — BiPAP (non-invasive)

IPAP supports inspiration, EPAP holds airway open. Via mask.

Set
IPAP · EPAP · Rate (optional) · FiO₂
Use
COPD exacerbation, cardiogenic pulmonary oedema, post-extubation support.
Pros
Avoids intubation; great for COPD/CPE.
Watch
Mask fit, vomiting/aspiration risk, claustrophobia.

NIV — CPAP (non-invasive)

Single continuous pressure; entirely spontaneous breathing.

Set
CPAP · FiO₂
Use
Cardiogenic pulmonary oedema, OSA, mild hypoxaemic failure.
Pros
Simple; recruits lungs; reduces preload in CPE.
Watch
No inspiratory support — not for fatigued patients.
Always confirm mode-specific settings against your unit's protocol and the patient's clinical trajectory.
Interpretation
Enter pH, PaCO₂ and HCO₃⁻ to interpret.
Always interpret alongside PaO₂, anion gap, lactate and the clinical picture.
MAP
Enter both systolic and diastolic values.
Sepsis bundle target is MAP ≥ 65 mmHg. Higher targets may be needed in chronic hypertension.
P/F ratio
Enter PaO₂ and FiO₂.
ARDS staging applies when PEEP ≥ 5 cm H₂O and the cause is not fully explained by cardiac failure.
GCS Total
15 / 15
Mild injury · E4 V5 M6
GCS ≤ 8 typically indicates the need for definitive airway management.
Assessment
0 Alert and calm
Spontaneously pays attention to caregiver.
Reassess at least every 4 hours and after any sedative titration. Pair with CAM-ICU for delirium screening.
Result
CAM-ICU negative
Delirium not present at this time.
Always start with a RASS assessment. If RASS is −4 or −5, the patient cannot be assessed for delirium.
CPOT total
0 / 8
No to mild pain
Self-report remains gold standard. Use CPOT only when patients cannot reliably communicate pain.
Total effluent
Enter weight + dose.
Citrate (4% solution)
Titrate to post-filter ionized Ca.
Replacement fluid
Pre- or post-filter
Dialysate
Counter-current to blood flow
Always confirm citrate dose against post-filter iCa and your unit's CRRT protocol. SCUF removes volume only — no solute clearance.
Bolus dose
IV push over 1 min
Drip rate
Pump setting
Always titrate against aPTT or anti-Xa per your institution's nomogram. Many protocols cap bolus at 10,000 units.
Oral MME
Standardised reference.
Equianalgesic dose
As Morphine — PO
Recommended start
After 30% reduction
Always apply incomplete cross-tolerance reduction (25–50 %) when rotating, and reassess pain within 24 hr.
QTc
Enter QT and HR to calculate.
Bazett over-corrects at high rates and under-corrects at low rates — prefer Fridericia outside HR 60–100.
Hourly rate
4-2-1 rule
24-hour total
100-50-20 rule
Use isotonic fluids (0.9% saline or balanced) per modern paediatric guidance. Adjust for ongoing losses, fever and clinical state.
Raw dose
Pre-cap
Administer
Within weight-based dose
Volume
From concentration
Always double-check paediatric doses against a current formulary and have a second clinician verify high-risk medications.
Result
Conversions are mathematical; always reconcile against the medication order before administering.
AnalyteReference rangeClinical note
Sodium (Na+)135-145 mEq/LHyponatremia/Hypernatremia
Potassium (K+)3.5-5.0 mEq/LCardiac arrhythmias risk
Chloride (Cl-)98-106 mEq/L
Bicarbonate (HCO3-)22-28 mEq/LAcid-base status
Calcium (Ca2+)8.5-10.5 mg/dLTetany/arrhythmia
Magnesium (Mg2+)1.5-2.5 mEq/LNeuromuscular, torsades
Creatinine0.6-1.3 mg/dLRenal function
BUN7-20 mg/dLRenal perfusion
Glucose (fasting)70-99 mg/dLDM screening
HemoglobinM 13.5-17.5 / F 12-16 g/dLAnemia
Platelets150-400 x10^3/µLBleeding risk
WBC4-11 x10^3/µLInfection/inflammation
pH (arterial)7.35-7.45Acid-base balance
PaCO235-45 mmHgRespiratory component
HCO3- (ABG)22-26 mEq/LMetabolic component
PaO280-100 mmHg (room air)Oxygenation
SaO2≥95%Oxygen saturation
Lactate0.5-2.0 mmol/LTissue hypoperfusion
Base Excess−2 to +2 mEq/LMetabolic status
Reference ranges vary by lab and patient population. Always cross-check the lab’s reported range.

These tools are study and practice aids. They are not a substitute for clinical judgement, organisational policy or pharmacist verification of high-risk medications.